Generic insulin, which could make the lifesaving treatment available to more diabietics, isn’t available because drug companies have acted to keep insulin under patent, according to researchers from Johns Hopkins. The study was published in the New England Journal of Medicine. The researchers said that insulin, which is used by 6 million people in the… Continue reading Drug Companies At Fault for Lack of Generic Insulin